Nerve Growth Factor Receptors and Signaling in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|6|463-470

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.6, 2004-09, pp. : 463-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Manipulation of the nerve growth factor network in prostate cancer

By Papatsoris Athanasios G   Liolitsa Danae   Deliveliotis Charalambos  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 303-309

Informa Healthcare

Access to resources Recommend Favorite

Growth Factor Signaling and Resistance to Cancer Chemotherapy

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 13, 2004-09 ,pp. : 1345-1354

Bentham Science Publishers

Access to resources Recommend Favorite

Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?

By Bruce David   Tan Peng H  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1413-1434

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

By Bose Chinmoy K  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 194-197

Reproductive Healthcare Ltd

Access to resources Recommend Favorite